ArticleTheranostics2021

Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer.

Qing Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.